Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
Medtronic Synchromed Pain Pump Failure Lawsuits. According to Medtronic’s news report in late 2016, their SynchroMed II implantable drug pump was linked to more than 100 adverse events including 2 previously unreported deaths.
Medtronic SynchroMed Pain Pump Lawsuits. The popular pain pump is beset with serious problems leading to over-dosage of pain medications including death.
In an October 2016 letter to doctors by the U.K.’s Medicines & Healthcare Products Regulatory Agency, Medtronic said the SynchroMed II pump can deliver too much medicine but that the exact cause of the over infusions isn’t clear.
Atrium C-Qur hernia mesh lawsuit update. As Atrium Medical, the company that manufactures the Atrium C-Qur hernia mesh comes under fire over its products, comes news that these product liability lawsuits are consolidated in New Hampshire for pre-trial proceedings.
Atrium C-Qur hernia mesh lawsuit blames mesh repair devices to abdominal injuries, infections and allergic reactions
The blood-thinner Xarelto can cause uncontrolled bleeding — a dangerous and possibly fatal side effect. Patients who say they were harmed by the drug and family members who lost a loved one to severe bleeding filed lawsuits against the manufacturer.
Xarelto is used to prevent blood clots from forming due to a certain irregular heartbeat or after hip or knee replacement surgery. It is also used to treat blood clots and to prevent the blood clots from forming again.
Lawsuits filed against the makers of Xarelto claim that the drug maker failed to warn consumers of the risk of severe bleeding that can result in death. Unlike other anticoagulant, such as Warfarin, severe bleeding from Xarelto does not have an antidote.
Pfizer, the pharmaceutical giant had a runaway hit on their hands when they developed and sold their blockbuster drug, Viagra. Now, allegations are surfacing in many Viagra melanoma lawsuits, claiming that Pfizer failed to warn patients and doctors about the melanoma skin cancer link associated with the erectile dysfunction medication.
Viagra Melanoma Lawsuits on the rise
Recently, two lawsuits were filed in the U.S. District Court for the Northern District of California, in which the plaintiffs allege that Pfizer knew or should have known about the melanoma skin cancer risk associated with Viagra for years.
According to Amador Herrara’s claim, Herrara was diagnosed with melanoma after using Viagra for many years.
Herrara has undergone many surgeries and alleges that he must remain watchful for the reappearance of the deadly skin cancer.
Another plaintiff, Dennis Andrews, filed a Viagra lawsuit, claiming that he developed malignant melanoma after using Viagra for many years. Andrews also underwent many surgeries and skin grafts. According to Andrews claims that must carefully monitor for signs of the melanoma skin cancer’s return.
Every year, thousands of patients are implanted with a retrieval inferior vena cava filters (IVC) but they are not warned by doctors about the risk of injury from these temporary devices.
And as time passes, patients tend to forget that they had this device implanted and the first inkling that they had the device, is when they suffer serious injury from a complication.
Starting tonight, on NBC Nightly News, there is a 2 part news segment about the dangers of the IVC devices and in particular the Bard IVC Recovery Filter device, its failure rate and the propensity to cause personal injury damage to patients. Shockingly many doctors who implant these devices are unaware of the risk and the dangers associated with these devices.
According to some experts, there is a very high failure rate with these devices, which only increases with the duration of the filter in the body, eventually all of the devices will fail. So 100% failure of the device becomes not a question of “if” but “when.”
What is an IVC Filter?
The filter devices are used when there is a blood clot in the leg known as a deep vein thrombosis and there is a contraindication to using blood thinners, which is the standard therapy for leg blood clots.
These devices are supposed to trap blood clots from traveling from the leg to the lungs and causing a pulmonary embolism, which can be fatal.
Total Number of DePuy ASR Settlements Exceeds 9,400 Cases
Johnson and Johnson (J&J) and its subsidiary DePuy Orthopaedics, has agreed to add another 1,400 hip injury claims to a settlement agreement reached in 2013. This new agreement extends the deal to include recalled ASR implants that were revised as of January 31, 2015.
In the most recent DePuy ASR defective metal hip trial, an Oklahoma woman has been awarded $2.5 million after suffering metal blood poisoning or metallosis from DePuy ASR hip replacements.
Andrea Smith, received ASR hip implants on each side in October 2006 and February 2007. Smith’s blamed DePuy in her lawsuit, claiming that she had to undergo revision surgery to have the implants removed in 2011 and 2012, after being diagnosed with high levels of Cobalt and Chromium metal ions in her blood.
There are over 75,000 women who have filed personal injury claims against the various manufacturers of the transvaginal and bladder sling products. According to sources, Johnson & Johnson has settled at least four Ethicon transvaginal mesh lawsuits.
These are the first few settlements reached out of over twenty thousand personal injury cases filed against the Johnson & Johnson Ethicon subsidiary company.
These settlements were reached in state court claims, and included a one wrongful death claim that alleged the vaginal mesh caused a deadly infection.
The U.S. District Judge overseeing the federal Actos litigation has issued orders requiring that the Court be provided with details about each of the cases filed, information about potential settlements and motions in various state courts throughout the country.There have been eight Actos Bladder Cancer trials to date across the United States. The majority of them have been held in various state courts and only one has been tried in the federal MDL out of thousands filed.The federal MDL case, a real bell ringer for Takeda, saw a Louisiana jury award over $9 billion – most of it in punitive damages – to the plaintiffs. The eye popping award was lowered in October to $38.1 million, and the jury was allowed to hear information that the judge sanctioned Takeda for destroying documents.Most recently, in November 2014, a jury fined Takeda $155,000 for destroying documents that could have helped plaintiff Richard Myers.The panel in that case found that Takeda officials intentionally destroyed the files.Takeda Pharmaceutical Co., was also ordered to pay more than $2 million to a plaintiff who claimed that the company’s Actos diabetes medicine caused her bladder cancer. Jurors in state court in Philadelphia found that the Japan-based Takeda failed to properly warn Frances Wisniewski’s doctors about Actos’s cancer risk.Federal Court Issues New OrdersJudge Doherty is requiring the parties to provide the Court with particularized information about each case pending in the federal court system.Defendants have been required to provide a summary of information contained on each plaintiffs’ fact sheet, including information on their exposure to Actos, medical history, bladder cancer treatments and other risk factors for the disease.Plaintiffs have been ordered to provide information about each case from the defendants’ fact sheet, outlining sales representative information received and any contact the drug companies had with the plaintiffs’ treating physicians.
Takeda Knew in 2004 of Cancer Link
According to court documents, Takeda knew by 2004 that studies found links between Actos and cancer, and didn’t issue a warning until seven years later to protect billions of dollars in Actos sales.
Today, the U.S. Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments to consolidate all federal Xarelto lawsuits before one judge, in one centralized U.S. District Court.
It is widely anticipated that the U.S. JPML will establish centralized proceedings for coordinated discovery and a series of bellwether trials.
Patients who took Xarelto accuse the drug manufacturers of downplaying Xarelto’s bleeding risks and asked that the cases be sent to U.S District Judge David Herndon in East St. Louis, Illinois. An order maybe granted before the upcoming holiday season.